It's all about me
23 November, 2007 by Kate McDonaldKari Stefansson's deCODE has launched an audacious online genome analysis service.
Phase II for flu
22 November, 2007 by Staff WritersBiota has begun a Phase II trial of its second generation flu treatment.
Slime-oozing fish sheds light on eye evolution
22 November, 2007 by Staff WritersAustralian researchers think they have discovered Darwin's missing link in the evolution of the eye.
Attractiveness is hereditary, dad says
22 November, 2007 by Staff WritersSexy dads produce sexy sons, in the insect world at least.
Smac-down for apoptosis
16 November, 2007 by Staff WritersInsect viral genes lead to discovery of human anti-apoptosis proteins.
From baker to brewer
02 November, 2007 by Fiona WylieRob Learmonth is using his fluorescence expertise to help the most needy - Australia's beer and wine drinkers.
Advance to San Diego
30 October, 2007 by Staff WritersApplications are open for the second Advancing BioBusiness Award.
Fowlpox vaccine released
29 October, 2007 by Staff WritersA vaccine for fowlpox developed by the CSIRO has been released commercially.
Strong debut for ImpediMed
25 October, 2007 by Kate McDonaldBrisbane biotech ImpediMed makes strong debut for lymphoedema diagnostic.
AusBiotech report: Novotech gets $8m boost
23 October, 2007 by Kate McDonald$8 million injection of funds to allow ANZ CRO Novotech to expand into Asia.
AusBiotech report: Farmacule scores big with Syngenta
22 October, 2007 by Kate McDonaldBrisbane's Farmacule will partner Syngenta and QUT to develop sugarcane-derived biofuels.
AusBiotech report: Gates offers novel grants for novel ideas
22 October, 2007 by Kate McDonaldFast-track grants of $100,000 available to small projects addressing big needs from Bill Gates Foundation.
AusBiotech report: Second generation biotech
22 October, 2007 by Kate McDonaldResearch Australia report says the source of original research for biotech companies is moving from the public to the private.
AusBiotech profile: ReWire Therapies
18 October, 2007 by Kate McDonaldReWire Therapies can probably boast one of the most impressive groups of company directors to be found in any biotechnology venture in Australia.
AusBiotech special: Australia's place in the global gravity shift
15 October, 2007 by Kate McDonaldWith AusBiotech 2007 being held in Brisbane next week, ALS takes its bi-annual survey of the state of the industry.
